Research Papers: Immunology:
Avian leukosis virus subgroup J induces VEGF expression via NFκB/PI3Kdependent IL6 production
PDF | Full Text | How to cite
Metrics: PDF 3010 views | Full Text 4271 views
Yanni Gao1, Yao Zhang1, Yongxiu Yao2, Xiaolu Guan1, Yongzhen Liu1, Xiaole Qi1, Yongqiang Wang1, Changjun Liu1, Yanping Zhang1, Honglei Gao1, Venugopal Nair2, Xiaomei Wang1 and Yulong Gao1
1 Division of Avian Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China
2 Avian Viral Diseases programme & UK-China Centre of Excellence on Avian Disease Research, The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK
Correspondence to:
Yulong Gao, email:
Keywords: ALV-J, interleukin 6, tumorigenesis, VEGF-A, VEGFR-2, Immunology and Microbiology Section, Immune response, Immunity
Received: July 13, 2016 Accepted: November 07, 2016 Published: November 10, 2016
Abstract
Avian leukosis virus subgroup J (ALV-J) is an oncogenic virus causing hemangiomas and myeloid tumors in chickens. Interleukin-6 (IL-6) is a multifunctional pro-inflammatory interleukin involved in many types of cancer. We previously demonstrated that IL-6 expression was induced following ALV-J infection in chickens. The aim of this study is to characterize the mechanism by which ALV-J induces IL-6 expression, and the role of IL-6 in tumor development. Our results demonstrate that ALV-J infection increases IL-6 expression in chicken splenocytes, peripheral blood lymphocytes, and vascular endothelial cells. IL-6 production is induced by the ALV-J envelope protein gp85 and capsid protein p27 via PI3K- and NF-κB-mediated signaling. IL-6 in turn induced expression of vascular endothelial growth factor (VEGF)-A and its receptor, VEGFR-2, in vascular endothelial cells and embryonic vascular tissues. Suppression of IL-6 using siRNA inhibited the ALV-J induced VEGF-A and VEGFR-2 expression in vascular endothelial cells, indicating that the ALV-J-induced VEGF-A/VEGFR-2 expression is mediated by IL-6. As VEGF-A and VEGFR-2 are important factors in oncogenesis, our findings suggest that ALV-J hijacks IL-6 to promote tumorigenesis, and indicate that IL-6 could potentially serve as a therapeutic target in ALV-J infections.